THE BEGINNING OF A NEW ERA IN ANTIBIOTIC DEVELOPMENT
15 May 2011
The ReAct seminar “The beginning of a new era in antibiotic development: Shaping of a new business model for life-saving innovation” in the European Parliament on March 29, is now available on video.
The event was moderated by Andrew Jack, Financial Times and co-hosted with two Members of the European Parliament, Christofer Fjellner, Sweden and Theodoros Skylakakis, Greece.
An edited summary with the key points of the event is available below, as well as the full presentations of the three speakers, Otto Cars - ReAct, Richard Bergström - EFPIA and Chantal Morel - LSE and the opening and closing statements from the MEPs.
News from the European Parliament - Antibiotic Resistance
Links to YouTube with full versions of the presentations on video
Christofer Fjellner och Andrew Jack (Introduction)
Theodoros Skylakakis (Concluding remarks)
Presentations from the meeting
An international network to improve the management of antibiotic resistance, Otto Cars, ReAct - Action on Antibiotic Resistance (pdf 663 KB)
Development of new antibiotics - the industry perspective, Richard Bergström, EFPIA - European Federation of the Pharmaceutical Industries and Associations (pdf 360 KB)
Exploring responses to the antibiotics crisis: incentivizing innovation and realigning R&D with medical need, Chantel Morel and Elias Mossialos, LSE - London School of Economics (pdf 225 KB)
- 16 May 2012HIGHLIGHTS FROM EPN FORUM 2012
- 03 May 2012RESISTANCE IN THE NEWS
- 25 Apr 2012RESISTANCE IN THE NEWS
- 19 Apr 20123Rs FOR INNOVATING NOVEL ANTIBIOTICS
- 18 Apr 2012RESISTANCE IN THE NEWS
- 11 Apr 2012RESISTANCE IN THE NEWS


